Arcturus Therapeutics Holdings Inc (ARCT) returns
Arcturus Therapeutics returns over 10 years
$1,000 invested in Arcturus Therapeutics ten years ago was worth $820.69 at the close on October 30, 2026, with dividends reinvested: an average return of -2.0% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -19.4% | — | $805.70 | -0.9% |
| 3 months | +86.3% | — | $1,863 | +2.1% |
| Year to date | +79.9% | — | $1,799 | +11.7% |
| 1 year | +14.5% | — | $1,145 | +12.4% |
| 3 years | -40.9% | -16.1% | $591.10 | +88.5% |
| 5 years | -75.5% | -24.5% | $245.38 | +76.0% |
| 10 years | -17.9% | -2.0% | $820.69 | +316.6% |
Arcturus Therapeutics return by calendar year
| Year | ARCT | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +79.9% | +11.7% | +68.2% |
| 2025 | -63.9% | +17.7% | -81.6% |
| 2024 | -46.2% | +24.9% | -71.1% |
| 2023 | +85.9% | +26.2% | +59.7% |
| 2022 | -54.2% | -18.2% | -36.0% |
| 2021 | -14.7% | +28.7% | -43.4% |
| 2020 | +299.1% | +18.4% | +280.7% |
| 2019 | +140.0% | +31.2% | +108.7% |
| 2018 | -43.0% | -4.6% | -38.5% |
| 2017 | -45.9% | +21.7% | -67.6% |
| 2016 | -66.6% | +12.0% | -78.6% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: ARCT financials
No forecast, no recommendation. This page describes Arcturus Therapeutics Holdings Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.